Even a year or two ago, the idea of digital therapeutics didn’t stir up a great amount of interest among most participants at ASAP’s BioPharma Conference, according to Mike Leonetti, president and CEO of ASAP. That sort of ambivalence no longer applies, as was evident at the September... Continue Reading
Blog
Your go-to source for coverage of the latest ASAP events, conferences, education, and more.
Looking to engage with our member community by contributing to ASAP’s content? Send your blog post, article draft, or idea to Kim Miller at kmiller@strategic-alliances.org